BIOTRONIK

BIOTRONIK Launches Implantable BioMonitor® - Highest Precision in Monitoring Arrhythmias

Thu, Oct 11, 2012 14:32 CET

ClearSense Technology with unique three-vector design offers superior detection of arrhythmias and efficient implantationBERLIN, Germany, October 11th, 2012—BIOTRONIK , a leading manufacturer of medical technology, today announced the European market release of BioMonitor® , a unique implantable cardiac device designed for the highly accurate and reliable monitoring and management of patients with atrial fibrillation (AF) or unexplained syncope.

BIOTRONIK demonstrates its commitment to Heart Failure Solutions with World’s First MR Approved CRT Devices at ESC Congress 2012

Fri, Aug 24, 2012 08:12 CET

BERLIN, Germany, August 23, 2012—BIOTRONIK , a leading manufacturer of innovative medical technology, is highlighting its broad, innovative and MRI (magnetic resonance imaging) approved implantable heart failure devices at the European Society of Cardiology congress , August 25-29, 2012. The latest BIOTRONIK cardiac resynchronization

First CRT-D Patient Enrolled in the EuroEco ICD/CRT-D Trial Assessing the Economic Effect of BIOTRONIK Home Monitoring®

Mon, Jul 23, 2012 16:10 CET

BERLIN, Germany, July 23, 2012 — BIOTRONIK announced today that the first CRT-D patient has been enrolled in the BIOTRONIK EuroEco Trial —the European Health Economic Trial on Home Monitoring in implantable cardioverter-defibrillator (ICD ) and cardiac resynchronization therapy device (CRT-D

Large-Scale BIOTRONIK SPIRIT-ICD Study Enrollment Complete

Thu, Jul 05, 2012 15:34 CET

SPIRIT-ICD study explores benefits of intensified diagnostic follow-up and timely therapeutic intervention for high-risk patient groupBERLIN, Germany, July 5, 2012—BIOTRONIK , a leading manufacturer of innovative medical technology, today announced that enrollment is now complete for the much anticipated SPIRIT-ICD study , with 503 patients from 37 sites in 11 countries worldwide registered. The SPIRIT-ICD study was initiated based on findings from

Share

BIOTRONIK Launches Implantable BioMonitor® - Highest Precision in Monitoring Arrhythmias

BIOTRONIK demonstrates its commitment to Heart Failure Solutions with World’s First MR Approved CRT Devices at ESC Congress 2012

First CRT-D Patient Enrolled in the EuroEco ICD/CRT-D Trial Assessing the Economic Effect of BIOTRONIK Home Monitoring®

Large-Scale BIOTRONIK SPIRIT-ICD Study Enrollment Complete

Media